This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
161. Results from a double-blind and open-label phase 3 study of a novel liquid formulation of abobotulinumtoxinA (Dysport) in the treatment of cervical dystonia. (January 2015)
Record Type:
Journal Article
Title:
161. Results from a double-blind and open-label phase 3 study of a novel liquid formulation of abobotulinumtoxinA (Dysport) in the treatment of cervical dystonia. (January 2015)
Main Title:
161. Results from a double-blind and open-label phase 3 study of a novel liquid formulation of abobotulinumtoxinA (Dysport) in the treatment of cervical dystonia